KeyBanc on Emerson (EMR): 'Risk/Reward Remains Compelling'
Tweet Send to a Friend
KeyBanc analyst Ken Newman reiterated an Overweight rating and $155.00 price target on Emerson (NYSE: EMR).The analyst commented: "We View ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
